Achieving patient-centricity under the new MDR - balancing stakeholder interests

22-23 October 2020 | Virtual Annual Conference

MPP2020 Program Day 1



Conference opening and welcome address

Shayesteh Fürst Ladani, SFL, President MPP Association

Welcome address

Karin Sartorius, Manager Life Sciences, Economic development, Office of Economy and Labour, Canton of Basel-Stadt

MPP2020 Program Committee Chair’s introduction

Daniel Diezi, Gerresheimer


Keynote address

Zaïde Frias, Head of the Digital Business Transformation Task Force, European Medicines
Agency (EMA)


Break & 1-on-1 partnering powered by Zühlke


Session 1 - New and emerging technologies

Chair: Michel Dard, Straumann

Data-driven business models – delivering value in the pharma & healthcare IoT

Daniel Weber, Detecon

Point-of-care transformation: bringing personalized care to the home setting

Frederik Mortier, Verhaert

Devices for drug delivery to the brain

Nico Stohler, Roche



Session 2 - Panel discussion on the Medical Devices Regulation and Combined Products

Chair: Shayesteh Fürst Ladani, SFL, President MPP Association

Erik Hansson, DG SANTE, European Commission
llona Reischl, Austrian Agency for Health and Food Safety – Austrian Medicines and Medical Devices Agency (AGES-MEA)
Serge Mathonet, Sanofi, EFPIA
Julia Frese, TÜV SÜD
Merlin Rietschel, Medtech Europe
Stephan Affolter, Ypsomed, MPP Board


Break & 1-on-1 partnering powered by Zühlke


Session 3 - From ideation to innovative products

Chair: Karin Schulze, SFL

Smart data in the service of patient safety

Goranka Tanackovic Abbas-Terki, Gene Predictis

Automated production of artificial personalized skin - A closed system for process automation

Daniela Marino, Cutiss & Reto Frei, Zühlke

Patenting strategies for startups, spinoffs and other projects based on patentable innovations at early stages

Christoph Klöckner, Winter, Brandl, Fürniss, Hübner, Röss, Kaiser, Polte – Partnerschaft

MPP2020 Program Day 2



Conference opening

Daniel Delfosse, Head Regulatory Affairs, Swiss Medtech, MPP Board


Session 4 - Innovation for successful development of healthcare products

Chair: Andy Tonazzi, Konplan systemhaus ag

Using modeling and simulation in the design of closed-loop medical devices

Sébastien Dupertuis, MathWorks

Using platforms to reduce the time and effort to bring new drug delivery combination products to the market

Christoph Muenzer, Novartis

Moore4Medical: towards open technology platforms for medical devices

Ronald Dekker, Philips


Break & 1-on-1 partnering powered by Zühlke


Session 5 - Patient/user needs in development of combined products

Chair: Dorit Prüfer, Roche

Promoting patient safety through new supply chain controls under the medical device regulation (MDR) and the falsified medicines directive (FMD)

Barbara Polek, SFL

Impact of falsified medicines – the patient perspective

Jan Geissler, Patvocates

Human centered design - process design for usability

Raimund Erdmann, Erdmann Design


Break & 1-on-1 partnering powered by Zühlke



Session 6 - Value-based healthcare in the combined products field and patient engagement

Chair: Marie Picci, Novartis & David Haerry, European AIDS Treatment Group

Effectively engaging patients to support product development and post-market success

Dominique Hamerlijnck, EUPATI

Building Trusted AI in Healthcare

Andrew Koubatis, Altran

Rising to the challenge of VBR, and other healthcare trends, using ‘4D’ therapeutic systems

Alex Booth, Full Spectrum Innovation


Closing remarks

Shayesteh Fürst Ladani, SFL, President MPP Association


Event Partner

Networking Partner

europa bio_0_0.png
  • Twitter Clean

© 2020 Medtech & Pharma Platform